Totally thoracoscopic beating-heart redo mitral valve surgery with hyperkalemic bradycardia: technique and early results Authors: Junyi Chen, Zijie Chen, Zheng Xu, Liangwan Chen, Xiaofu Dai Published: 2026 ABSTRACT AbstractBackgroundAlthough beating-heart redo mitral valve (MV) surgery has been previously documented in several reports, experience with totally thoracoscopic reoperations remains limited. The present study was undertaken to describe our institutional experience with totally thoracoscopic beating-heart redo MV surgery employing a systemic hyperkalemic bradycardia technique during cardiopulmonary bypass (CPB) and to assess its early clinical outcomes.MethodsA comprehensive retrospective review of the database was undertaken from September 2020 to January 2026. Patients undergoing totally thoracoscopic redo MV surgery via right minithoracotomy (MINI group) were compared with those managed by conventional resternotomy (CON group). Perioperative variables and early clinical outcomes were subjected to comparative statistical analysis.ResultsA total of 111 patients were included (43 MINI, 68 CON). The MINI group had shorter CPB time (104.7±18.7 vs. 121.4±10.0 min), total operative time (179.4±37.9 vs. 233.0±25.9 min), and intraoperative blood loss (142.0±67.0 vs. 364.6±153.5 mL), with significantly fewer red blood cell (0.8±1.7 vs. 2.2±1.5 units) and plasma transfusions (7.0±25.8 vs. 97.8±121.7 mL) (all P<0.001). The MINI group also had reduced chest drainage, shorter ventilation time, decreased intensive care unit (ICU) stay and reduced total hospital stay (all P<0.001). Hospital cost was lower in the MINI group [95,206±6,126 vs. 125,149±14,526 Chinese Yuan (CNY), P<0.001]. The incidence of postoperative pneumonia was significantly lower in the MINI group [11.6% vs. 30.9%; odds ratio (OR) =3.40, 95% confidence interval (CI): 1.16–9.98, P=0.02]. No cases of reoperation for bleeding, extracorporeal membrane oxygenation (ECMO), stroke, or mortality occurred in the MINI group.ConclusionsTotally thoracoscopic beating-heart redo mitral surgery employing hyperkalemic bradycardia reduces blood transfusion requirements, lowers hospital costs, and shortens length of stay compared with the conventional method. This technique appears safe and effective, and may be appropriately considered for carefully selected patients requiring redo MV surgery.Keywords: Thoracoscopic, beating-heart, redo mitral surgery Highlight box Key findings • Totally thoracoscopic beating-heart redo mitral surgery with hyperkalemic bradycardia is a safe and preferable alternative for carefully selected patients. What is known and what is new? • Redo mitral valve (MV) surgery via standard median sternotomy with or without cross-clamping is technically more demanding and carries higher perioperative risk. • This study provides a novel, minimally invasive and safe surgical alternative for redo MV surgery. What is the implication, and what should change now? • In this study, we found that patients treated with totally thoracoscopic beating-heart redo mitral surgery had fewer blood transfusion requirements, lower hospital costs, and shorter length of stay compared with the conventional method, indicating that this technique is a safe and feasible approach for redo mitral surgery. Nevertheless, long-term follow-up should be conducted to assess durability of valve repair or replacement and late survival. Introduction Over the past two decades, the increasing use of prosthetic valves has led to a growing number of patients requiring redo mitral valve (MV) surgery (1). Reoperations on the MV now account for more than 10% of all mitral procedures performed annually (2). Redo MV surgery via standard median sternotomy is technically more demanding and carries higher perioperative risk (3). Although transcatheter mitral interventions have expanded treatment options for some high-risk patients, many younger individuals and those with contraindications to transcatheter approaches still require surgical reoperation. Several former studies have shown satisfactory clinical outcomes of redo mitral surgery via minimally invasive approach using hypothermic fibrillatory arrest or aortic cross-clamping (3-10). In this study, we therefore review our experience with totally thoracoscopic beating-heart redo mitral surgery using the hyperkalemic bradycardia technique. This study retrospectively evaluates and compares the early clinical outcomes of mini redo mitral surgery and the conventional redo mitral surgery via standard resternotomy. We present this article in accordance with the STROBE reporting checklist (available at https://jtd.amegroups.com/article/view/10.21037/jtd-2026-1014/rc). Methods This study was conducted in accordance with the Declaration of Helsinki and its subsequent amendments. The study was approved by the ethics committee of Fujian Medical University Union Hospital (No. 2026KY573), the requirement for individual patient consent was waived due to the retrospective nature of the study. Data were collected from the patients between September 2020 and January 2026 who underwent redo MV surgery at our institute. Inclusion criteria Lone redo MV surgery following a previous cardiac surgery via standard median sternotomy; Lone redo MV surgery following a previous cardiac surgery via standard median sternotomy; Without aortic valve disease (moderate-to-severe aortic regurgitation and/or stenosis); Without aortic valve disease (moderate-to-severe aortic regurgitation and/or stenosis); No history of right-sided chest trauma, surgery, or radiotherapy; No history of right-sided chest trauma, surgery, or radiotherapy; No imaging evidence of right-sided adhesions. No imaging evidence of right-sided adhesions. Exclusion criteria Severe coronary artery disease; Severe coronary artery disease; Aortic valve disease (moderate-to-severe aortic regurgitation and/or stenosis); Aortic valve disease (moderate-to-severe aortic regurgitation and/or stenosis); Dilation of the ascending aorta or aortic aneurysm; Dilation of the ascending aorta or aortic aneurysm; History of right-sided chest trauma, surgery, or radiotherapy; History of right-sided chest trauma, surgery, or radiotherapy; Imaging evidence of right-sided adhesions; Imaging evidence of right-sided adhesions; Hemodynamically unstable conditions or those who underwent emergency or salvage procedures. Hemodynamically unstable conditions or those who underwent emergency or salvage procedures. Patients underwent MV surgery with either a MINI approach performed by 2 surgeons (X.D., L.C.) or conventional resternotomy (CON) performed by 5 different surgeons, including those who performed MINI. Operative protocol Anesthesia and monitoring A standardized anesthetic protocol was uniformly applied across both groups. External defibrillation pads were positioned posteriorly prior to induction. Following anesthetic administration, double-lumen endotracheal intubation was performed to enable selective right lung ventilation, with position confirmed bronchoscopically both before and after patient positioning. Standard monitoring included right radial arterial pressure measurement and transesophageal echocardiography (TEE), with probes placed while the patient remained supine. Nasopharyngeal temperature was continuously recorded throughout the procedure. Central venous access was established in all patients for administration of inotropic or vasopressor agents. Additionally, patients in the MINI group underwent percutaneous right internal jugular cannulation to facilitate subsequent superior vena cava drainage (Figure 1A). Surgical positioning, incision and cannulation. (A) Right jugular vein cannulation; (B) supine position with elevated right hemithorax; (C) right anterior mini-incision; (D) femoral artery and vein cannulations. Positioning and incision For the MINI group, patients were positioned supine with the right hemithorax moderately elevated and the operating table flexed to optimize exposure of the fourth intercostal space (Figure 1B). A 4 cm primary working incision was typically created in the fourth intercostal space, approximately 1cm anterior to the anterior axillary line, with location guided by the position of the pulmonary hilum on preoperative chest radiography. A separate 2 cm thoracoscopic port was placed approximately 2 cm posteriorly in the same intercostal space (Figure 1C). Patients in the CON group were positioned supine without modification. Cardiopulmonary bypass (CPB) management CPB was established according to a standardized institutional protocol. The circuit was primed with crystalloid solution under sterile conditions. In the MINI group, the femoral vessels were exposed via a 2–3 cm vertical groin incision, and two separate 5-0 Prolene purse-string sutures were placed on the femoral artery and vein, respectively (Figure 1D). Following systemic heparinization, cannulation was performed using the Seldinger technique under TEE guidance. Venous cannulation was accomplished by advancing a long multistage cannula into the mid-right atrium via the right femoral vein over a guidewire; arterial cannulation was performed in a similar fashion. CPB was instituted with right femoral arterial inflow and vacuum-assisted venous drainage from both the femoral and internal jugular cannulas. Non-pulsatile flow was maintained at a high-output index of 2.5–3.0 L/min/m2 using a roller pump (Stöckert S5) and a hollow-fiber membrane oxygenator (Sorin INSPIRE 6F or Terumo CX*FX25RW). Mean arterial pressure was targeted to 60–80 mmHg, and nasopharyngeal temperature was maintained under mild hypothermic conditions (35 ℃). Hematocrit was maintained between 23% and 27%, with oxygen saturation at 100%. Systemic hyperkalemia was induced by controlled administration of potassium chloride, titrated to achieve serum concentrations of 6–8 mmol/L based on empirical calculation and serial blood gas analyses, thereby gradually reducing the heart rate to below 35 beats per minute. The required potassium dose was calculated using the following formula: 0.3 × body weight (kg) × [target serum potassium (mmol/L) − baseline serum potassium (mmol/L)]. Supplemental esmolol was administered as needed if heart rate fluctuated during MV manipulation. Rapid reversal of hyperkalemia was accomplished prior to cardiac chamber closure using a combination of sodium bicarbonate infusion, furosemide, intravenous calcium gluconate, and a glucose-insulin injection, augmented by hemofiltration during CPB. In the CON group, myocardial protection was achieved using a conventional perfusion strategy with antegrade cardioplegia, consisting of either HTK (histidine-tryptophan-ketoglutarate) or Del Nido solution. Surgical technique In the MINI group, soft-tissue retractors were utilized to enhance surgical field exposure and protect the incision without rib fracture. The right lung was deflated and retracted posteriorly. As previously described by our colleagues (11), left ventricular venting catheter and carbon dioxide delivery tubing were routinely prepared. Following longitudinal atriotomy via the right atrium or interatrial groove, redo MV surgery was performed during the interval between two consecutive heartbeats (Video 1). All patients were positioned in Trendelenburg and rotated to elevate the left atrium relative to the left ventricle. Continuous TEE monitoring was employed to verify aortic valve competence throughout the procedure. The surgical field was continuously flooded with carbon dioxide, and meticulous de-airing was performed through the left atriotomy prior to closure. Following TEE confirmation of valve function and cardiac performance, CPB was discontinued according to standard criteria, and all incisions were closed. Patients in the CON group underwent standard median sternotomy for surgical exposure with central arterial and venous cannulation. All CON procedures were performed with aortic cross-clamping, and myocardial protection consisted of antegrade cardioplegia. Conventional instruments were employed, with mitral repair or replacement performed using standard techniques comparable to those in the MINI group. Thoracoscopic beating-heart redo mitral valve replacement. Perioperative management Patients were monitored in the intensive care unit (ICU) after surgery and transferred to the ward after hemodynamic stabilization. Routine chest X-rays and laboratory tests were performed to rule out postoperative complications. A transthoracic echocardiography was performed before discharge. Statistical analysis Clinical information was collected including basic and demographic data of patients, medical history, results of laboratory tests, surgery, and postoperative treatment. Data were presented as the proportions (%) and the mean and standard deviation for categorical variables and numeric variables, respectively. Chi-squared or Fisher’s exact test for categorical variables, Student’s t-test or Mann-Whitney U test for continuous data as appropriate. The SPSS 24.0 was used as statistical software, and defined P values <0.05 as statistical significance. Results Baseline characteristics A total of 111 patients were included in our study (Table 1): 43 patients (mean age 52.5±8.7 years, 34.9% men) underwent mini redo mitral surgery and 68 patients (54.9±9.7 years, 45.6% men) underwent conventional redo mitral surgery. The two groups were well-balanced regarding most baseline characteristics (all P>0.05). Preoperative laboratory findings including hemoglobin, alanine transaminase (ALT), potassium, creatinine, troponin I, and lactic acid were also comparable between groups (all P>0.05). However, the MINI group had lower preoperative left ventricular ejection fraction (LVEF) compared with the CON group (53.8%±10.2% vs. 59.7%±10.1%, P=0.006), while preoperative pulmonary artery pressure was similar between the two groups (50.7±19.9 vs. 50.0±10.2 mmHg, P=0.41). Table 1Demographic and clinical characteristicsVariableMINI group (n=43)CON group (n=68)P valueDemographic characteristics Gender (Male)15 (34.9)31 (45.6)0.27 Age (years)52.5±8.754.9±9.70.18 BMI (kg/m2)23.8±3.723.2±4.10.23Clinical characteristics Previous surgery interval (months)78.4±35.376.0±21.60.94 NYHA functional class0.20 Class II1 (2.3)1 (1.4) Class III35 (81.4)62 (91.2) Class IV7 (16.3)5 (7.4)Echocardiographic data Left ventricular ejection fraction (%)53.8±10.259.7±10.10.006 Preoperative pulmonary artery pressure (mmHg)50.7±19.950.0±10.20.70Previous surgery history Mitral valve repair15 (34.9)24 (35.3)0.97 Mitral valve replacement21 (48.8)32 (47.1)0.86 Aortic valve replacement6 (14.0)9 (17.6)0.92 Atrial septal defect repair1 (2.3)3 (4.4)0.57Current pathology Ring pannus8 (18.6)16 (23.5)0.54 Endocarditis4 (9.3)9 (13.2)0.53 Paravalvular leak11 (25.6)13 (20.6)0.42 Mitral regurgitation22 (51.2)30 (42.6)0.47Comorbidities Hypertension10 (23.3)17 (25.0)0.68 Cerebral infarction1 (2.3)2 (2.9)0.70 Diabetes mellitus4 (9.3)6 (8.8)0.87Laboratory findings Hemoglobin (g/L)115.7 ±14.4113.2± 11.40.07 Alanine transaminase (U/L)42.9±7.545.4±12.10.25 Baseline potassium (mmol/L)4.46±0.664.47±0.740.99 Creatinine (μmol/L)73.0±19.574.6±11.10.71 Troponin I (ng/mL)0.024±0.0080.023±0.0060.66 Lactic acid (mmol/L)1.03±0.311.11±0.260.14Data presented as mean ± standard deviation for continuous variables, or n (%) for categorical variables. Statistical tests: Chi-squared or Fisher’s exact test for categorical variables, Student’s t-test or Mann-Whitney U test for continuous data as appropriate. CON group, conventional resternotomy group; MINI group, totally thoracoscopic redo mitral valve surgery via right minithoracotomy group. BMI, body mass index; NYHA, New York Heart Association. Demographic and clinical characteristics Data presented as mean ± standard deviation for continuous variables, or n (%) for categorical variables. Statistical tests: Chi-squared or Fisher’s exact test for categorical variables, Student’s t-test or Mann-Whitney U test for continuous data as appropriate. CON group, conventional resternotomy group; MINI group, totally thoracoscopic redo mitral valve surgery via right minithoracotomy group. BMI, body mass index; NYHA, New York Heart Association. Intraoperative data The MINI group demonstrated significantly shorter operative times compared with the conventional group (Table 2). CPB time was significantly reduced in the MINI group (104.7±18.7 vs. 121.4±10.0 min, P<0.001), as was total operation time (179.4±37.9 vs. 233.0±25.9 min, P<0.001). Intraoperative blood loss was substantially lower in the MINI group (142.0±67.0 vs. 364.6±153.5 mL, P<0.001). Consequently, the MINI group required significantly fewer blood transfusions, including red blood cells (0.8±1.7 vs. 2.2±1.5 units, P<0.001) and plasma (7.0±25.8 vs. 97.8±121.7 mL, P<0.001). In addition, Table S1 describes perioperative key coagulation parameters between groups. The types of surgical procedures performed, including MV replacement, MV repair, and paravalvular leak repair, were similar between the two groups (all P>0.05). Table 2Intra- and postoperative dataVariableMINI group (n=43)CON group (n=68)P valueIntraoperative data CPB time (min)104.7±18.7121.4±10.0<0.001 Aortic cross-clamp time (min)–84.0±9.7– Bradycardia time (min)88.1±18.1–– Operation time (min)179.4±37.9233.0±25.9<0.001 Serum potassium (mmol/L)7.02±0.594.97±0.59<0.001 Intraoperative blood loss (mL)142.0±67.0364.6±153.5<0.001 Red blood cell transfusion (units)0.8±1.72.2±1.5<0.001 Plasma transfusion (mL)7.0±25.897.8±121.7<0.001Surgical procedures Mitral valve replacement29 (67.4)47 (69.1)0.73 Mitral valve repair9 (20.9)13 (19.1)0.67 Paravalvular leak repair5 (11.6)8 (11.8)0.98Postoperative data Postoperative chest drainage (mL)123.9±53.8446.8±162.2<0.001 Ventilation time (hours)13.6±4.824.6±13.3<0.001 ICU stay (hours)24.5±10.058.5±15.9<0.001 Total hospital stay (days)9.6±2.313.2±2.4<0.001 Total cost (RMB)95,206±6,126125,149±14,526<0.001Data presented as mean ± standard deviation for continuous variables, or n (%) for categorical variables. Statistical tests: Chi-squared or Fisher’s exact test for categorical variables, Student’s t-test or Mann-Whitney U test for continuous data as appropriate. CON group, conventional resternotomy group; MINI group, totally thoracoscopic redo mitral valve surgery via right minithoracotomy group. CPB, cardiopulmonary bypass; ICU, intensive care unit. Intra- and postoperative data Data presented as mean ± standard deviation for continuous variables, or n (%) for categorical variables. Statistical tests: Chi-squared or Fisher’s exact test for categorical variables, Student’s t-test or Mann-Whitney U test for continuous data as appropriate. CON group, conventional resternotomy group; MINI group, totally thoracoscopic redo mitral valve surgery via right minithoracotomy group. CPB, cardiopulmonary bypass; ICU, intensive care unit. Postoperative outcomes Postoperative chest drainage was markedly reduced in MINI patients compared with CON patients (123.9±53.8 vs. 446.8±162.2 mL, P<0.001). The MINI group also demonstrated significantly shorter ventilation time (13.6±4.8 vs. 24.6±13.3 h, P<0.001), ICU stay (24.5±10.0 vs. 58.5±15.9 h, P<0.001), and total hospital stay (9.6±2.3 vs. 13.2±2.4 d, P<0.001). Total hospital cost was substantially lower in the MINI group (95,206±6,126 vs. 125,149±14,526 CNY, P<0.001). Postoperative laboratory and echocardiographic findings Table 3 summarizes the postoperative data. Postoperative laboratory tests revealed significant differences between groups. The MINI group had significantly lower ALT, lower creatinine, and lower lactic acid levels compared with the conventional group. Postoperative potassium and troponin I levels were similar between groups (both P>0.05). Table 3Comparison of echo and laboratory findings between two groupsVariableMINI group (n=43)CON group (n=68)P valueLVEF (%) Preoperative53.8±10.259.7±10.10.001 Postoperative62.2±4.258.6±9.40.12 P value (pre vs. post)<0.0010.660–Pulmonary artery pressure (mmHg) Preoperative50.7±19.950.0±10.20.41 Postoperative27.9±4.136.1±6.3<0.001 P value (pre vs. post)<0.001<0.001–Hemoglobin (g/L) Preoperative115.7±14.4113.2±11.40.39 Postoperative102.6±8.996.7±13.00.02 P value (pre vs. post)<0.001<0.001–ALT (U/L) Preoperative42.9±7.545.4±12.10.28 Postoperative53.6±16.064.2±19.60.003 P value (pre vs. post)<0.001<0.001–Serum potassium (mmol/L) Preoperative4.49±0.664.47±0.740.78 Postoperative4.49±0.604.55±0.640.75 P value (pre vs. post)0.8940.488–Creatinine (μmol/L) Preoperative73.0±19.575.7±11.70.73 Postoperative73.8±13.897.4±13.0<0.001 P value (pre vs. post)0.960<0.001–Troponin I (ng/mL) Preoperative0.024±0.0080.023±0.0060.42 Postoperative0.038±0.0300.071±0.2340.30 P value (pre vs. post)0.0200.105–Lactic acid (mmol/L) Preoperative1.03±0.311.11±0.260.22 Postoperative0.92±0.411.13±0.450.041 P value (pre vs. post)0.1780.967–Data presented as mean ± standard deviation for continuous variables. Statistical tests: Chi-squared or Fisher’s exact test for categorical variables, Student’s t-test or Mann-Whitney U test for continuous data as appropriate. CON group, conventional resternotomy group; MINI group, totally thoracoscopic redo mitral valve surgery via right minithoracotomy group. LVEF, left ventricular ejection fraction; ALT, alanine transaminase. Comparison of echo and laboratory findings between two groups Data presented as mean ± standard deviation for continuous variables. Statistical tests: Chi-squared or Fisher’s exact test for categorical variables, Student’s t-test or Mann-Whitney U test for continuous data as appropriate. CON group, conventional resternotomy group; MINI group, totally thoracoscopic redo mitral valve surgery via right minithoracotomy group. LVEF, left ventricular ejection fraction; ALT, alanine transaminase. Echocardiographic assessment showed that while preoperative LVEF was lower in the MINI group, postoperative LVEF became comparable between groups (62.2%±4.2% vs. 58.6%±9.4%, P=0.12). Notably, the MINI group achieved a significant improvement in LVEF postoperatively (53.8%±10.2% to 62.2%±4.2%, P<0.001), whereas the conventional group showed no significant change. Both groups demonstrated significant reductions in pulmonary artery pressure postoperatively (both P<0.001), but the MINI group achieved significantly lower postoperative pulmonary artery pressure compared with the conventional group. Within-group comparisons showed that the conventional group experienced significant postoperative increases in ALT and creatinine (both P<0.05). Both groups had significant decreases in hemoglobin postoperatively (both P<0.001). Troponin I increased significantly in the MINI group postoperatively (P=0.02), while the increase in the conventional group was not statistically significant (P=0.11). Postoperative complications The incidence of pneumonia was significantly lower in the MINI group compared with the conventional group [11.6% vs. 30.9%; odds ratio (OR) =3.40, 95% confidence interval (CI): 1.16–9.98, P=0.02]. Although other complications such as CRRT (continuous renal replacement therapy), reoperation for bleeding, intra-aortic balloon pump (IABP), extracorporeal membrane oxygenation (ECMO), stroke, and mortality occurred more frequently in the conventional group, these differences did not reach statistical significance (all P>0.05). No cases of reoperation for bleeding, ECMO, stroke, or mortality were observed in the MINI group (Table 4). Table 4Postoperative complicationComplicationsMINI group (n=43)CON group (n=68)P valueOR (95% CI)Pneumonia5 (11.6)21 (30.9)0.023.40 (1.16–9.98)CRRT1 (2.3)7 (10.3)0.154.82 (0.57–40.8)Reoperation for bleeding0 (0)3 (4.4)0.284.52 (0.23–89.6)IABP1 (2.3)3 (4.4)0.671.93 (0.19–19.2)ECMO0 (0)1 (1.5)>0.991.93 (0.08–48.5)Stroke0 (0)1 (1.5)>0.991.93 (0.08–48.5)Mortality0 (0)1 (1.5)>0.991.93 (0.08–48.5)Data presented as n (%) for categorical variables. Statistical tests: Chi-squared or Fisher’s exact test for categorical variables as appropriate. OR calculated with MINI group as reference; OR calculated with Haldane-Anscombe correction for zero cells. CON group, conventional resternotomy group; MINI group, totally thoracoscopic redo mitral valve surgery via right minithoracotomy group. CI, confidence interval; CRRT, continuous renal replacement therapy; IABP, intra-aortic balloon pump; ECMO, extracorporeal membrane oxygenation; OR, odds ratio. Postoperative complication Data presented as n (%) for categorical variables. Statistical tests: Chi-squared or Fisher’s exact test for categorical variables as appropriate. OR calculated with MINI group as reference; OR calculated with Haldane-Anscombe correction for zero cells. CON group, conventional resternotomy group; MINI group, totally thoracoscopic redo mitral valve surgery via right minithoracotomy group. CI, confidence interval; CRRT, continuous renal replacement therapy; IABP, intra-aortic balloon pump; ECMO, extracorporeal membrane oxygenation; OR, odds ratio. Discussion Key clinical observations In 43 redo mitral surgeries via a thoracoscopic approach, early outcomes were favorable with excellent mitral exposure in all cases. Total operative time was significantly shorter than with conventional resternotomy, reflecting improved procedural efficiency even in the redo setting. There were no iatrogenic injuries, reexplorations for bleeding, or postoperative strokes, and all patients were discharged uneventfully. Comparative advantages over conventional resternotomy Simplicity and technical feasibility The technique is simple, using only standard equipment without specialized devices or extra suction. Systemic hyperkalemia induces bradycardia and left ventricular decompression. A single left atrial suction cannula provides adequate drainage and keeps the field clean while minimizing trauma to blood elements. In the interval between two heartbeats, an experienced surgeon can manipulate the MV with precision equivalent to aortic cross-clamping. Reduced bleeding and transfusion Intraoperative blood loss and transfusion requirements were significantly reduced in the MINI group, likely due to avoidance of extensive mediastinal dissection and adhesiolysis. Postoperative hemoglobin was also higher in the MINI group, reflecting a lower hemorrhagic burden. Faster recovery Ventilation time, ICU stay, and total hospital stay were all significantly shorter in the MINI group, reflecting faster recovery. Fewer complications Complications were fewer, especially pneumonia (11.6% vs. 30.9%; OR =3.40, 95% CI: 1.16–9.98, P=0.02). Other adverse events—including acute kidney injury requiring CRRT, reoperation for bleeding, IABP, ECMO, stroke, and death—were numerically more frequent in the CON group, with zero cases in the MINI group for reoperation for bleeding, ECMO, stroke, or death. Lower cost Total hospital cost was significantly lower in the MINI group (95,206±6,126 vs. 125,149±14,526 CNY, P<0.001). By eliminating cardioplegic solution, reducing transfusions, and shortening recovery time, we achieved savings of approximately 30,000 CNY. This demonstrates that better clinical outcomes need not come at a higher cost, an important consideration in today’s healthcare environment. Comparison with previous reports Unlike the deep hypothermic strategies commonly used in fibrillatory arrest (typically 26–28 ℃) (5,8), we used mild hypothermic CPB at 35 ℃. This temperature preserves the myocardial protective effects of cooling and minimizes hypothermia-related coagulopathy and organ injury (8,10,12). By avoiding aortic cross-clamping, we do not need to dissect around a hostile aorta—a risky maneuver in patients with porcelain aorta or patent grafts (2,6). We also avoid transthoracic or endovascular balloon occlusion devices (4,5,13), which simplifies the procedure and reduces cost. The procedure is associated with consistently low rates of major complications and reduced blood transfusion requirements. Wang and colleagues (14) reported similar findings: their minimally invasive redo mitral patients used fewer blood products and had shorter hospital stays, even with higher preoperative risk. The low rates of low cardiac output syndrome and stroke in our study also support the safety of this approach (9,15). The mini technique allows a main 4 cm incision just large enough to accommodate the appropriately sized prosthetic valve (Figure 2), minimizing chest wall trauma while maintaining excellent visualization of the MV. This is an improvement over right thoracotomy approaches that often require larger incisions and rib spreading, which may contribute to increased postoperative pain and pulmonary complications (7). Thoracoscopic assistance helps with visualization and precise valve implantation or repair, with outcomes similar to conventional sternotomy (3,4). A 4 cm mini-incision. Myocardial protection and organ perfusion Conventional CPB strategy can cause myocardial edema and potentially impair postoperative ventricular function. It also contributes to systemic hypoperfusion, reflected in biochemical markers. Our data support this concern. In the CON group, postoperative ALT and creatinine rose significantly (both P<0.001), indicating greater physiologic stress, whereas the MINI group maintained stable renal and hepatic function. The MINI group also had lower postoperative lactate levels (0.92±0.41 vs. 1.13±0.45 mmol/L, P=0.041), suggesting better perfusion and metabolic preservation. Notably, despite a lower preoperative LVEF in the MINI group (53.8%±10.2% vs. 59.7%±10.1%, P=0.006), LVEF improved markedly after surgery (53.8%±10.2% to 62.2%±4.2%, P<0.001), whereas the conventional group showed no significant change (59.7%±10.1% to 58.6%±9.4%, P=0.66). Postoperative LVEF was similar between groups (62.2%±4.2% vs. 58.6%±9.4%, P=0.12), suggesting that the beating-heart technique does not compromise myocardial preservation and may offer advantages in patients with lower preoperative LVEF. A small-scale randomized trial previously reported no significant cellular or mitochondrial injury with either cardioplegic arrest or beating-heart techniques for valve replacement, concluding that both are safe with minimal procedure-related mortality (16). By maintaining continuous coronary perfusion, this technique avoids myocardial hypoxia and ischemia-reperfusion injury. The use of 35 ℃ mild hypothermia perfusion reduces the risk of hypothermia-induced coagulopathy while still providing cardioprotective cooling benefits. Safety considerations and mitigation strategies Systemic hyperkalemia One potential concern with systemic hyperkalemia is that excessively high serum potassium could, in theory, cause organ dysfunction. Hori and colleagues (17) previously described the successful application of hyperkalemia- and hypothermia-mediated myocardial protection in a patient with prior coronary surgery undergoing ascending aorta replacement, followed by uneventful recovery. In the present study, we saw no clinical or biochemical evidence of hyperkalemia-related problems. Postoperative potassium levels were similar between groups (4.49±0.60 vs. 4.55±0.64 mmol/L, P=0.75), indicating that intraoperative hyperkalemia is transient and reversible, with no lasting sequelae. Nevertheless, routine monitoring and avoidance of excessive potassium administration remain essential. Air embolism prevention Preventing air embolism is the biggest challenge in beating-heart mitral manipulation. In our 43 patients, we had no neurological complications. Our preventive strategy includes: continuous intraoperative TEE to verify aortic valve competence; high-flow retrograde arterial perfusion to increase afterload and keep the aortic valve closed; Trendelenburg positioning before opening the heart; evacuating left ventricular air by rendering the MV incompetent with a vent, so that the unloaded ventricle does not eject residual air; and supplemental carbon dioxide insufflation. With these precautions, air escape from the ventricle is highly unlikely provided that the aortic valve remains competent. Potential quality of life (QOL) improvement Our colleagues recently reported that thoracoscopic double valve replacement reduced early postoperative pain and hospital stay, and improved SF-36 scores at three months compared with median sternotomy (18). Although our study did not directly assess QOL, the MINI group showed less blood loss, fewer transfusions, shorter ventilation time, shorter ICU and hospital stays, and lower costs—all of which suggest a recovery trajectory consistent with better short-term QOL. Study limitations Several limitations of this study warrant acknowledgment. First, this was a non-randomized retrospective study with inherent bias including selection bias and surgeon bias. Second, the sample size was relatively small, particularly for the MINI group, which precluded subgroup analysis or multivariable regression to adjust for potential confounders. Third, all procedures were performed at a single institution by experienced surgeons, which may limit generalizability. Fourth, long-term follow-up data were not available to assess durability of valve repair or replacement and late survival. Fifth, we did not formally assess QOL using validated instruments such as SF-36; thus, the potential QOL benefits of this approach remain speculative and require confirmation in future studies. Conclusions Despite these limitations, our findings demonstrate that this totally thoracoscopic redo mitral surgery is associated with significantly reduced operative trauma, faster recovery, lower costs, and better postoperative organ function compared to conventional sternotomy, so it may be a better choice for selected patients. Supplementary The article’s supplementary files as Acknowledgments None. Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The study was conducted in accordance with the Declaration of Helsinki and its subsequent amendments. The study was approved by the ethics committee of Fujian Medical University Union Hospital (No. 2026KY573), and individual consent for this retrospective analysis was waived. Footnotes Reporting Checklist: The authors have completed the STROBE reporting checklist. Available at https://jtd.amegroups.com/article/view/10.21037/jtd-2026-1014/rc Funding: None. Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-2026-1014/coif). The authors have no conflicts of interest to declare. Data Sharing Statement Available at https://jtd.amegroups.com/article/view/10.21037/jtd-2026-1014/dss References Available at https://jtd.amegroups.com/article/view/10.21037/jtd-2026-1014/prf Supplementary Materials The article’s supplementary files as Data Availability Statement Available at https://jtd.amegroups.com/article/view/10.21037/jtd-2026-1014/dss